重症急性胰腺炎治疗中的外科干预

Surgical intervention in the treatment of severe acute pancreatitis

重症急性胰腺炎(SAP)病死率可达30%,其发病率仍在逐年上升,带来严重的经济与社会负担。近半数SAP患者可于病程后期发生感染性胰腺坏死等局部并发症,其治疗以控制感染及其相关并发症为主。随着微创治疗技术的发展,以微创技术为核心的“升阶梯”治疗策略改善了患者预后,外科干预在此治疗过程中极为关键,主要体现在准确掌控外科干预的指征、时机和方式。本文就SAP的外科干预策略进行阐述,以期进一步优化SAP患者的整体治疗。

Severe acute pancreatitis(SAP)has a mortality rate of up to 30%,and its incidence continues to rise each year,posing a significant economic and social burden.Nearly half of SAP patients may develop local complications such as infected pancreatic necrosis in the later stages of the disease,with treatment focused on controlling infection and its associated complications.With the development of minimally invasive treatment techniques,the"step-up"treatment strategy centered on minimally invasive techniques has improved patient outcomes.Surgical intervention plays a critical role in this treatment process,primarily by accurately determining the indications,timing,and methods for surgical intervention.This article discusses surgical intervention strategies for SAP,aiming to optimize the holistic treatment of SAP patients further.